• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; VALVE REPAIR Back to Search Results
Catalog Number CDS0502
Device Problem Incomplete Coaptation (2507)
Patient Problems Mitral Regurgitation (1964); Respiratory Distress (2045); Tissue Damage (2104); Heart Failure (2206)
Event Date 09/14/2020
Event Type  Injury  
Manufacturer Narrative
The clip remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This filed to report single leaflet device attachment/slda, tissue damage, worsening mitral regurgitation, heart failure, respiratory distress, prolonged hospitalization, and surgical intervention.It was reported that this was a mitraclip procedure to functional mitral regurgitation (mr) with a grade of 3-4.It was noted restricted posterior mitral leaflet.On (b)(6) 2020, two clips were implanted, reducing mr to 1.Then on (b)(6) 2020, the patient experienced respiratory distress and heart failure symptoms.Imaging showed the second clip was detached from the anterior leaflet but remained attached to the posterior leaflet (single leaflet device attachment/slda), worsening mr to 4.The other clip was stable on both leaflets.The physician stated the cause of the slda was due to the tearing of the anterior leaflet.The patient remained hospitalized.On (b)(6) 2020, the patient underwent mitral valve replacement for additional treatment.The surgery was successful and the patient is stable.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.The investigation determined the reported single leaflet device attachment/slda appears to be related to the tissue damage (tearing of the anterior leaflet).The reported worsening mitral regurgitation (mr), respiratory distress, and heart failure appear to be due to the procedural condition of the slda.A cause for the tissue damage cannot be determined.Worsening mitral regurgitation (mr), tissue damage, respiratory distress, and heart failure are listed in the instructions for use as known possible complications associated with mitraclip procedures.The reported hospitalization and surgical procedure were results of case specific circumstance.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key10608422
MDR Text Key209237982
Report Number2024168-2020-08136
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 11/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/03/2021
Device Catalogue NumberCDS0502
Device Lot Number00402U240
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/15/2020
Initial Date FDA Received09/30/2020
Supplement Dates Manufacturer Received11/09/2020
Supplement Dates FDA Received11/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
1 IMPLANTED MITRACLIP; 1 IMPLANTED MITRACLIP
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age52 YR
Patient Weight84
-
-